Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Large-scale testing (Phase 3)Study completedNCT00003805What this trial is testingPrevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountWho this might be right forBone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Study completedNCT00088231What this trial is testingPTK 787 and Gleevec in Patients With AML, AMM, and CML-BPWho this might be right forAcute Myelogenous LeukemiaAgnogenic Myeloid MetaplasiaChronic Myelogenous Leukemia M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Ended earlyNCT00354172What this trial is testingDonor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.Who this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 16
Early research (Phase 1)Study completedNCT00005967What this trial is testingTipifarnib in Treating Patients With Advanced Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Looking for participantsNCT02115295What this trial is testingCladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid LeukemiaWho this might be right forAcute Biphenotypic LeukemiaAcute Myeloid LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+11 more M.D. Anderson Cancer Center 508